Picture of Decoy Therapeutics logo

DCOY — Decoy Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Salarius Pharmaceuticals Appoints Daniela Santiesteban To Director Of Targeted Protein Degradation Program

Feb 3 (Reuters) - Salarius Pharmaceuticals Inc  SLRX.O :
    * SALARIUS PHARMACEUTICALS APPOINTS DANIELA SANTIESTEBAN,
PH.D.,
TO DIRECTOR OF TARGETED PROTEIN DEGRADATION PROGRAM

Source text for Eikon:  ID:nGNX2fRbw0 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Decoy Therapeutics

See all news